An experienced antitrust lawyer, Alicia Batts has a well-established practice representing clients in mergers and acquisitions, as well as general investigations, before federal and state agencies. Her agency and counseling practice includes consumer protection matters before the FTC and state authorities. Her federal antitrust litigation practice spans the full range of antitrust and unfair competition-related litigation, including class actions and competitor suits.

    Earlier in her career, Alicia served as an Attorney Advisor to Federal Trade Commissioner Mozelle Thompson, for whom she reviewed antitrust actions before the FTC and made recommendations on enforcement and policy matters before the federal antitrust agency.

    Alicia’s experience, both as a government antitrust attorney and as a trusted legal and business advisor to high-profile multinational companies, brings invaluable insight on issues critical to clients. In particular, Alicia has considerable experience offering sophisticated services to clients in the pharmaceutical and chemicals industries.

    Alicia served as vice-chair of the Emerging Issues in Healthcare Law Conference Planning Committee, and also served as vice-chair of the Antitrust Section Business Torts & Civil RICO Committee, Antitrust Section Litigation Task Force and Clayton Act Committee. Alicia was also a member of the editorial board of the Antitrust Law Journal.

    Alicia was recognized as one of “America’s Top Black Lawyers.” U.S. News and World Report recognized the Competition – Antitrust Practice in its Best Law Firms Rankings.

    Award Mouse thought multimedia interface book medal screen monitor
    • Providing antitrust advice to a consortium, which includes suppliers in a highly concentrated industry, bidding to acquire a national specialty retailer.
    • Successfully defended Sherman Act and state law claims filed against a conglomerate.
    • Representing an auto parts manufacturer in various matters before the DOJ.
    • Representing a major publisher before the DOJ and the FTC.
    • Representing Grifols S.A. in its US$4.1 billion acquisition of Talecris Biotherapeutics Holdings Corp. and its US$1.7 billion agreement to acquire the transfusion unit of Novartis Vaccines & Diagnostics, Inc.
    • Representing an investor group in a US$6 billion acquisition, which was recognized as The American Lawyer’s 2014 Global M&A Deal of the Year.
    • Representing the Lonza Group in its US$1.4 billion tender for Arch Chemicals, Inc., resulting in the early termination of the HSR waiting period.
    • Representing Visa International, defending two separate Sherman Act Section One and Two claims filed by American Express and Discover Financial Services.
    • Representing hospital systems and associations before the federal antitrust agencies and courts.

    Education

    • Columbia Law School, J.D.
    • Harvard College, A.B.

    Admissions

    • District of Columbia, 1993
    • New York, 1991

    {{insights.date}} {{insights.source}} {{insights.type}}

    • Moderator, “A Day in the Life of Plaintiff Lawyer,” ABA Section of Antitrust, October 16, 2018.
    • Presenter, “Insurance Mergers – Efficiencies and Monopsony Power,” ABA Section of Antitrust Law, ABA Section of Health Law and the American Health Lawyers Association, May 17, 2018.
    • Author, ABA Health Law Section and Bloomberg BNA Pharmaceutical and Medical Device Law, Chapter 11: Antitrust and Intellectual Law Issues for Pharmaceutical Companies, 2015 and updates 2016, 2017 and 2018.
    • Author, “Innovation, Antitrust and the Trump Administration,” Investor's Business Daily, April 20, 2017.
    • Author, “Business should think carefully about their communications with suppliers and distributors who are also competitors,” Business Insights, October 25, 2016.
    • Presenter, “Blue Cross Blue Shield Antitrust Litigation: Update on the issues,” ABA Antitrust Section, May 4, 2016.
    • Presenter, “Sherman’s (and Clayton’s) March: Emerging Issues in Antitrust Enforcement,” ABA 2016 Section of Litigation Annual Conference, Chicago, April 15, 2016.
    • Author, “Ninth Circuit Sides with FTC; Affirms Ruling That Idaho Health Care Merger Was Unlawful,” Client Alert, February 11, 2015.
    • Author, Practical Law’s Multi-Jurisdictional Guide 2014/15 Competition and Cartel Leniency, Restraints of Trade and Dominance in the United States: Overview, July 2014.

    Award Mouse thought multimedia interface book medal screen monitor